Paliperidone protects prefrontal cortical neurons from damages caused by MK-801 via Akt1/GSK3β signaling pathway

Schizophrenia Research

Volumn 147, Issue 1, 2013, Pages 14-23

  Peng, Lei ^a   Zhu, Dexiao ^a   Feng, Xiaowen ^a   Dong, Haiman ^a   Yue, Qingwei ^a   Zhang, Jing ^a   Gao, Qing ^a   Hao, Jing ^a   Zhang, Xingzhen ^b   Liu, Zengxun ^a   Sun, Jinhao ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Paliperidone; Prefrontal cortical neurons; Protection; Schizophrenia

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CALCIUM; DIZOCILPINE; LACTATE DEHYDROGENASE; PALIPERIDONE; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN NERVE CELL; CALCIUM CELL LEVEL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG INHIBITION; EMBRYO; ENZYME ACTIVITY; ENZYME METABOLISM; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; IN VITRO STUDY; INTRACELLULAR SIGNALING; MOUSE; NERVE CELL INHIBITION; NERVE CELL LESION; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVE FIBER GROWTH; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; TIME SERIES ANALYSIS; TREATMENT OUTCOME;

ANIMALS; ANTIPSYCHOTIC AGENTS; CALCIUM; CELL SURVIVAL; CELLS, CULTURED; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GLYCOGEN SYNTHASE KINASE 3; ISOXAZOLES; L-LACTATE DEHYDROGENASE; MICE; NEURITES; NEURONS; PREFRONTAL CORTEX; PREGNANCY; PROTO-ONCOGENE PROTEINS C-AKT; PYRIMIDINES; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTOME;

EID: 84877128755     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.03.006     Document Type: Article

References (47)

1. Corbett R. Clozapine but not haloperidol antagonizes an MK-801 discriminative stimulus cue. Pharmacol. Biochem. Behav. 1995, 51(2-3):561-564.
2. de Olmos S., Bender C., de Olmos J.S., Lorenzo A. Neurodegeneration and prolonged immediate early gene expression throughout cortical areas of the rat brain following acute administration of dizocilpine. Neuroscience 2009, 164(3):1347-1359.
3. Deutsch S.I., Rosse R.B., Billingslea E.N., Bellack A.S., Mastropaolo J. Topiramate antagonizes MK-801 in an animal model of schizophrenia. Eur. J. Pharmacol. 2002, 449(1-2):121-125.
4. Dickerson J., Sharp F.R. Atypical antipsychotics and a Src kinase inhibitor (PP1) prevent cortical injury produced by the psychomimetic, noncompetitive NMDA receptor antagonist MK-801. Neuropsychopharmacology 2006, 31(7):1420-1430.
5. Dummler B., Hemmings B.A. Physiological roles of PKB/Akt isoforms in development and disease. Biochem. Soc. Trans. 2007, 35(Pt 2):231-235.
6. Emamian E.S., Hall D., Birnbaum M.J., Karayiorgou M., Gogos J.A. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat. Genet. 2004, 36(2):131-137.
7. Frangou S., Murray R.M. Imaging as a tool in exploring the neurodevelopment and genetics of schizophrenia. Br. Med. Bull. 1996, 52(3):587-596.
8. Franke T.F. PI3K/Akt: getting it right matters. Oncogene. 2008, 27(50):6473-6488.
9. Freyberg Z., Ferrando S.J., Javitch J.A. Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action. Am. J. Psychiatry. 2009, 167(4):388-396.
10. Gassó P., Mas S., Molina O., Bernardo M., Lafuente A., Parellada E. Neurotoxic/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 36(1):71-77.
11. Hoffman D.C. Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats. J. Neural. Transm. Gen. Sect. 1992, 89(1-2):1-10.
12. Hwang J.Y., Kim Y.H., Ahn Y.H., Wie M.B., Koh J.Y. N-Methyl-d-aspartate receptor blockade induces neuronal apoptosis in cortical culture. Exp. Neurol. 1999, 159(1):124-130.
13. Johnstone E.C., Frith C.D. Validation of three dimensions of schizophrenic symptoms in a large unselected sample of patients. Psychol. Med. 1996, 26(4):669-679.
14. Kandel E.S., Hay N. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp. Cell Res. 1999, 253(1):210-229.
15. Kim N.R., Park S.W., Lee J.G., Kim Y.H. Protective effects of olanzapine and haloperidol on serum withdrawal-induced apoptosis in SH-SY5Y cells. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32(3):633-642.
16. Kinon B.J., Lieberman J.A. Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacology (Berl). 1996, 124(1-2):2-34.
17. Klimaviciusa L., Safiulina D., Kaasik A., Klusa V., Zharkovsky A. The effects of glutamate receptor antagonists on cerebellar granule cell survival and development. Neurotoxicology 2008, 29(1):101-108.
18. Koprivica V., Regardie K., Wolff C., Fernalld R., Murphy J.J., Kambayashi J., Kikuchi T., Jordan S. Aripiprazole protects cortical neurons from glutamate toxicity. Eur. J. Pharmacol. 2011, 651(1-3):73-76.
19. Koros E., Dorner-Ciossek C. The role of glycogen synthase kinase-3beta in schizophrenia. Drug News Perspect. 2007, 20(7):437-445.
20. Kozlovsky N., Shanon-Weickert C., Tomaskovic-Crook E., Kleinman J.E., Belmaker R.H., Agam G. Reduced GSK-3beta mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients. J. Neural Transm. 2004, 111(12):1583-1592.
21. Kurosawa S., Hashimoto E., Ukai W., Toki S., Saito S., Saito T. Olanzapine potentiates neuronal survival and neural stem cell differentiation: regulation of endoplasmic reticulum stress response proteins. J. Neural Transm. 2007, 114(9):1121-1128.
22. Lai W.S., Xu B., Westphal K.G., Paterlini M., Olivier B., Pavlidis P., Karayiorgou M., Gogos J.A. Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(45):16906-16911.
23. Leung J.C., Ragland N., Marphis T., Silverstein D.M. NMDA agonists and antagonists induce renal culture cell toxicity. Med. Chem. 2008, 4(6):565-571.
24. Lin C.H., Yeh S.H., Lin C.H., Lu K.T., Leu T.H., Chang W.C., Gean P.W. A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron 2001, 31(5):841-851.
25. Markus A., Zhong J., Snider W.D. Raf and akt mediate distinct aspects of sensory axon growth. Neuron. 2002, 35(1):65-76.
26. Manahan-Vaughan D., Wildförster V., Thomsen C. Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter-1 (GlyT1). Eur. J. Neurosci. 2008, 28(7):1342-1350.
27. Massana G., Salgado-Pineda P., Junqué C., Pérez M., Baeza I., Pons A., Massana J., Navarro V., Blanch J., Morer A., Mercader J.M., Bernardo M. Volume changes in gray matter in first-episode neuroleptic-naive schizophrenic patients treated with risperidone. J. Clin. Psychopharmacol. 2005, 25(2):111-117.
28. Nadri C., Dean B., Scarr E., Agam G. GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients. Schizophr. Res. 2004, 71(2-3):377-382.
29. Namikawa K., Honma M., Abe K., Takeda M., Mansur K., Obata T., Miwa A., Okado H., Kiyama H. Akt/protein kinase B prevents injury-induced motoneuron death andaccelerates axonal regeneration. J. Neurosci. 2000, 20(8):2875-2886.
30. Olney J.W., Labruyere J., Wang G., Wozniak D.F., Price M.T., Sesma M.A. NMDA antagonist neurotoxicity: mechanism and prevention. Science 1991, 254(5037):1515-1518.
31. Ono T., Hashimoto E., Ukai W., Ishii T., Saito T. The role of neural stem cells for in vitro models of schizophrenia: neuroprotection via Akt/ERK signal regulation. Schizophr. Res. 2010, 122(1-3):239-247.
32. Park S.W., Lee C.H., Lee J.G., Kim L.W., Shin B.S., Lee B.J., Kim Y.H. Protective effects of atypical antipsychotic drugs against MPP(+)-induced oxidative stress in PC12 cells. Neurosci. Res. 2011, 69(4):283-290.
33. Peineau S., Bradley C., Taghibiglou C., Doherty A., Bortolotto Z.A., Wang Y.T., Collingridge G.L. The role of GSK-3 in synaptic plasticity. Br. J. Pharmacol. 2008, 153(Suppl. 1):S428-S437.
34. Sadock B.J., Sadock V.A., Ruiz P., Kaplan H.I. Kaplan and Sadock's Comphrehensive Textbook of Psychiatry 2009, Williams and Wilkins, Philadelphia.
35. Scherk H., Falkai P. Effects of antipsychotics on brain structure. Curr. Opin. Psychiatry 2006, 19(2):145-150.
36. Schmidt A.J., Krieg J.C., Clement H.W., Hemmeter U.M., Schulz E., Vedder H., Heiser P. Effects of quetiapine, risperidone, 9-hydroxyrisperidone and ziprasidone on the survival of human neuronal and immune cells in vitro. J. Psychopharmacol. 2010, 24(3):349-354.
37. Shadach E., Gaisler I., Schiller D., Weiner I. The latent inhibition model dissociates between clozapine, haloperidol, and ritanserin. Neuropsychopharmacology. 2000, 23(2):151-161.
38. Tao-Cheng J.H., Vinade L., Smith C., Winters C.A., Ward R., Brightman M.W., Reese T.S., Dosemeci A. Sustained elevation of calcium induces Ca(2+)/calmodulin-dependent protein kinase II clusters in hippocampal neurons. Neuroscience. 2001, 106(1):69-78.
39. Tiedtke P.I., Bischoff C., Schmidt W.J. MK-801-induced stereotypy and its antagonism by neuroleptic drugs. J. Neural. Transm. Gen. Sect. 1990, 81(3):173-182.
40. Vlahos C.J., Matter W.F., Hui K.Y., Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 1994, 269(7):5241-5248.
41. Walker E.H., Pacold M.E., Perisic O., Stephens L., Hawkins P.T., Wymann M.P., Williams R.L. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol. Cell 2000, 6(4):909-919.
42. Wyatt R.J., Henter I.D. The effects of early and sustained intervention on the long-term morbidity of schizophrenia. J. Psychiatr. Res. 1998, 32(3-4):169-177.
43. Xi D., Li Y.C., Snyder M.A., Gao R.Y., Adelman A.E., Zhang W., Shumsky J.S., Gao W.J. Group II metabotropic glutamate receptor agonist ameliorates MK801-induced dysfunction of NMDA receptors via the Akt/GSK-3β pathway in adult rat prefrontal cortex. Neuropsychopharmacology 2011, 36(6):1260-1274.
44. Xiao Q., Wang C., Li J., Hou Q., Li J., Ma J., Wang W., Wang Z. Ginkgolide B protects hippocampal neurons from apoptosis induced by beta-amyloid 25-35 partly via up-regulation of brain-derived neurotrophic factor. Eur. J. Pharmacol. 2010, 647(1-3):48-54.
45. Yang M.C., Lung F.W. Neuroprotection of paliperidone on SH-SY5Y cells against β-amyloid peptide(25-35), N-methyl-4-phenylpyridinium ion, and hydrogen peroxide-induced cell death. Psychopharmacology (Berl.) 2011, 217(3):397-410.
46. Yang Z.Z., Tschopp O., Di-Poï N., Bruder E., Baudry A., Dümmler B., Wahli W., Hemmings B.A. Dosage-dependent effects of Akt1/protein kinase Balpha (PKBalpha) and Akt3/PKBgamma on thymus, skin, and cardiovascular and nervous system development in mice. Mol. Cell. Biol. 2005, 25(23):10407-10418.
47. Yulug B., Yildiz A., Hüdaoglu O., Kilic E., Cam E., Schäbitz W.R. Olanzapine attenuates brain damage after focal cerebral ischemia in vivo. Brain Res. Bull. 2006, 71(1-3):296-300.